SLCO1B1 Variants and Statin-Induced Myopathy — A Genomewide Study

The SEARCH Collaborative Group·2008·New England Journal of Medicine

DOI 10.1056/nejmoa0801936

Cited by (1,002)

Items 901–1,000 of 1,002

Molecular pathways associated with blood pressure and hexadecanedioate levels
Cristina Menni, Sarah Metrustry, Georg Ehret, Anna F. Dominiczak, Phil Chowienczyk, Tim D. Spector, Sandosh Padmanabhan, Ana Maria Valdes · 2017 · PLoS ONE
Evidence of Drug-Drug Interactions through Uptake and Efflux Transport Systems in Rat Hepatocytes: Implications for Cellular Concentrations of Competing Drugs
Youssef Daali, P. Millet, Pierre Dayer, Catherine M. Pastor · 2013 · Drug Metabolism and Disposition
Prescribing high-dose lipid-lowering therapy early to avoid subsequent cardiovascular events: is this a cost-effective strategy?
Roberta Ara, Abdullah Pandor, John Stevens, Rachid Rafia, Sue E. Ward, Alan Rees, Paul N. Durrington, Tim Reynolds, Anthony S. Wierzbicki, Matt Stevenson · 2011 · European Journal of Preventive Cardiology
Genetics and hypertension: is it time to change my practice?
Delles, Christian, Padmanabhan, Sandosh · 2012 · Canadian Journal of Cardiology
Lipid Lowering Therapy Utilization and Lipid Goal Attainment in Women
Julie A E van Oortmerssen, Janneke W.C.M. Mulder, Marte F. van der Bijl, Ruben J M Mijnster, Maryam Kavousi, Jeanine E. Roeters van Lennep · 2025 · Current Atherosclerosis Reports
Emphasizing Statin Safety in the Hospitalized Patient: A Review
Alicia Leung, Élise Schaefer, Michael W. Tempelhof, Neil J. Stone · 2012 · The American Journal of Medicine
Statin-induced muscle toxicity and susceptibility to malignant hyperthermia and other muscle diseases: a population-based case-control study including 1st and 2nd degree relatives
Karin Hedenmalm, Arzu Güneş Granberg, Marja‐Liisa Dahl · 2014 · European Journal of Clinical Pharmacology
Using systems approaches to address challenges for clinical implementation of pharmacogenomics
Jason H. Karnes, Sara L. Van Driest, Erica Bowton, Peter Weeke, Jonathan D. Mosley, Josh F. Peterson, Joshua C. Denny, Dan M. Roden · 2013 · WIREs Systems Biology and Medicine
Pharmacogenetics at 50: Genomic Personalization Comes of Age
Thomas Jacob Urban, David B. Goldstein · 2012 · Science Translational Medicine
Possible gene-gender interaction between the SLCO1B1 polymorphism and statin treatment efficacy.
Jaroslav Alois Hubacek, Dana Dlouhá, Vera Adámkova, Vera Lanska, R Češka, Michal Vrablı́k · 2012 · PubMed
Multiple Factors Govern the Association between Pharmacology and Toxicity in a Class of Drugs: Toward a Unification of Class Effect Terminology
Dennis A. Smith, Anthony C. Harrison, Paul Morgan · 2011 · Chemical Research in Toxicology
8‐acetoxy‐trisulfopyrene as the first activatable fluorogenic probe for add‐and‐read assessment of Organic anion‐transporting polypeptides, OATP1B1, OATP1B3, and OATP2B1
Orsolya Ungvári, Laura Király, Éva Bakos, Csilla Özvegy‐Laczka · 2021 · The FASEB Journal
Rhabdomyolysis during concomitant ticagrelor and rosuvastatin: A breast cancer resistance protein‐mediated drug interaction?
Minna Lehtisalo, Wilma Kiander, Anne M. Filppula, Feng Yu Deng, Heidi Kidron, Mari K. Korhonen, Johanna Sinkko, Kimmo Koivula, Mikko Niemi · 2023 · British Journal of Clinical Pharmacology
Pharmacogenomics of Cardiovascular Drugs for Atherothrombotic, Thromboembolic and Atherosclerotic Risk
Alfredo Mauriello, Antonia Ascrizzi, Riccardo Molinari, Luigi Falco, Alfredo Caturano, Antonello D’Andrea, Vincenzo Russo · 2023 · Genes
The impact of SLCO1B1 rs4149056 on LDL-C target achievement after lipid lowering therapy optimization in men and women with familial hypercholesterolemia
Giosiana Bosco, Francesco Di Giacomo Barbagallo, Maurizio Di Marco, Nicoletta Miano, Sabrina Scilletta, Salvatore Spampinato, Alessio Vitale, Federica Di Bella, Maria Eva Montalbano, Stefania Di Mauro et al. · 2024 · Frontiers in Endocrinology
Characterizing the genetic architecture of drug response using gene-context interaction methods
Michał Sadowski, Mike Thompson, Joel Mefford, Tanushree Haldar, Akinyemi Oni‐Orisan, Richard Border, Ali Pazokitoroudi, Na Cai, Julien F. Ayroles, Sriram Sankararaman et al. · 2024 · Cell Genomics
Next generation sequencing and rare genetic variants: From human population studies to medical genetics
G. Matullo, C. Di Gaetano, S. Guarrera · 2013 · Environmental and Molecular Mutagenesis
Pharmacogenomics and Cardiovascular Disease
Peter Weeke, Dan M. Roden · 2013 · Current Cardiology Reports
Review of the Cost Effectiveness of Pharmacogenetic-Guided Treatment of Hypercholesterolaemia
Michael Joseph Sorich, Michael David Wiese, Rebekah O’Shea, Brita A. K. Pekarsky · 2013 · PharmacoEconomics
Pharmacogenomic diversity in Singaporean populations and Europeans
Liam R. Brunham, Sze Ling Chan, R Li, Folefac Aminkeng, X Liu, Woei‐Yuh Saw, Rick Twee‐Hee Ong, Nisha E. Pillai, Bruce Carleton, Dorothy Toh et al. · 2014 · The Pharmacogenomics Journal
Plasma Membrane Transporters in Modern Liver Pharmacology
José J.G. Marı́n · 2012 · Scientifica
Expression and Activity of ABCG2, but not ABCB1 or OATP1B1, are Associated with Cholesterol Levels: Evidence from in Vitro and in Vivo Experiments
Kenneth K.W. To, Miao Hu, Brian Tomlinson · 2014 · Pharmacogenomics
Open Access Integrated Therapeutic and Diagnostic Platforms for Personalized Cardiovascular Medicine
Patrick A. Gladding, Andrew Cave, Mehran Zareian, Kevin K. Smith, Jagir R. Hussan, Peter John Hunter, Folarin Erogbogbo, Zoraida P. Aguilar, David O. Martin, Eugene Chan et al. · 2013 · Journal of Personalized Medicine
PHarmacogenomics and Adverse Drug Reactions
Shashi Amur, Issam Zineh, Darrell R Abernethy, Shiew-Mei Huang, Lawrence J. Lesko · 2010 · Personalized Medicine
Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202
Valentine Wanga, Charles S. Venuto, Gene D. Morse, Edward P. Acosta, Eric S. Daar, David W. Haas, Chun Li, Bryan E. Shepherd · 2015 · Pharmacogenetics and Genomics
Rare variants in known and novel candidate genes predisposing to statin-associated myopathy.
M. Neroldova, V. Stránecký, K. Hodaňová, H. Hartmannová, L. Piherová, A. Přistoupilová, L. Mrázová, M. Vrablík, V. Adámková, J. Hubáček et al. · 2016 · Pharmacogenomics (London)
Statin-Induced Autoimmune Necrotizing Myopathy
Sahani Jayatilaka, Kunal Desai, Swarup Sharma Rijal, Debra Zimmerman · 2021 · Journal of Primary Care & Community Health
SLCO1B1 Genetic Variants, Long-Term Low-Density Lipoprotein Cholesterol Levels and Clinical Events in Patients Following Cardiac Catheterization
Josephine H. Li, Sunil Suchindran, Svati Hasmukh Shah, William E. Kraus, Geoffrey S. Ginsburg, Deepak Voora · 2015 · Pharmacogenomics
Use of Statin Therapy to Reduce Cardiovascular Risk in Older Patients
Nanette Kass Wenger, Sandra J. Lewis · 2010 · Current Gerontology and Geriatrics Research
Avoiding statin myopathy: understanding key drug interactions
Charles Harold Harper, Terry A. Jacobson · 2011 · Clinical Lipidology
Genome Wide Association Study for Predictors of Progression Free Survival in Patients on Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in First-Line Therapy of Metastatic Colorectal Cancer
Jan Pander, Lieke H. van Huis‐Tanja, Stefan Böhringer, Tahar van der Straaten, Hans A. J. Gelderblom, Cornelis J.A. Punt, Henk‐Jan Guchelaar · 2015 · PLoS ONE
Simvastatin-induced myopathy, the role of interaction with diltiazem and genetic predisposition
Miao Hu, Valiant W.L. Mak, Brian Tomlinson · 2010 · Journal of Clinical Pharmacy and Therapeutics
Rhabdomyolysis and acute kidney injury secondary to concomitant use of fluvastatin and rapamycin in a renal transplant recipient
Nikolina Bašić‐Jukić, P. Kes, Ljubica Bubić-Filipi, Zoran Vranjican · 2010 · Nephrology Dialysis Transplantation
Statin Myopathy: Significant Problem With Minimal Awareness by Clinicians and no Emphasis by Clinical Investigators
Thomas F. Whayne · 2011 · Angiology
The role of statins in amyotrophic lateral sclerosis: protective or not?
Hayder Mutter Al-Kuraishy, Majid Sakhi Jabir, Ghassan Mohammad Sulaiman, Hamdoon Abdelhamid Mohammed, Ali Ismail Al-Gareeb, Ali K. Albuhadily, Sabrean Farhan Jawad, Ayman A. Swelum, Mosleh Mohammad Abomughaid · 2024 · Frontiers in Neuroscience
Current progress in pharmacogenetics
John Blakey, Ian P. Hall · 2011 · British Journal of Clinical Pharmacology
Treatment of dyslipidemia in idiopathic inflammatory myositis: results of the International Myositis Assessment and Clinical Studies Group survey
Christina Charles‐Schoeman, Sogol Amjadi, Harold E. Paulus · 2012 · Clinical Rheumatology
GENETICS/GENOMICS AND DRUG EFFECTS
F. Heller · 2013 · Acta Clinica Belgica
A Current Approach to Statin Intolerance
Rose O. Tompkins, Arthur Z. Schwartzbard, Eugenia Gianos, Edward A A Fisher, HOWARD S. WEINTRAUB · 2014 · Clinical Pharmacology & Therapeutics
Prevalencia de síndrome de Gilbert y sus determinantes genéticas en población chilena
Luis Méndez, Marcela Lagos L, Teresa Quiroga, Paula Margozzini, Lorena Azócar, Héctor Molina, Alejandra Vera-Leiva, Luis Antonio Villarroel, Marco A. Arrese, Jochen Hampe et al. · 2013 · Revista médica de Chile
Polymorphisms of the nuclear receptor pregnane X receptor and organic anion transporter polypeptides 1A2, 1B1, 1B3, and 2B1 are not associated with breast cancer risk
Christina Justenhoven, Elke Schaeffeler, Stefan Winter, Christian Baisch, Ute Hamann, Volker Harth, Sylvia Rabstein, Anne Lotz, Beate Pesch, Thomas Brüning et al. · 2010 · Breast Cancer Research and Treatment
Skeletal muscle cell MHC I expression: Implications for statin‐induced myopathy
Pratibha Singh, Danielle Kohr, Manfred Kaps, Franz Blaes · 2009 · Muscle & Nerve
Statin Pharmacogenomics: Opportunities to Improve Patient Outcomes and Healthcare Costs with Genetic Testing
William J. Canestaro, David G. Brooks, Donald Chaplin, Niteesh K. Choudhry, Elizabeth V. Lawler, Lori A. Martell, Troyen A. Brennan, Edward Robert Wassman · 2012 · Journal of Personalized Medicine
Individualised therapy of angiotensin converting enzyme (ACE) inhibitors in stable coronary artery disease: overview of the primary results of the PERindopril GENEtic association (PERGENE) study
Jasper Jan Brugts, Moniek P.M. de Maat, A.H. Jan Danser, Eric H. Boersma, Maarten L. Simoons · 2011 · Netherlands Heart Journal
Dissecting complex traits: recent advances in hypertension genomics
Kevin M. O’Shaughnessy · 2009 · Genome Medicine
Reviewing statin therapy in diabetes—Towards the best practise
Niina Matikainen, Juhani Kahri, Marja‐Riitta Taskinen · 2010 · Primary care diabetes
An integrative method for scoring candidate genes from association studies: application to warfarin dosing
Nicholas P. Tatonetti, Joel T. Dudley, Hersh Sagreiya, Atul Janardhan Butte, Russ Biagio Altman · 2010 · BMC Bioinformatics
Multilocus Genotypes of Relevance for Drug Metabolizing Enzymes and Therapy with Thiopurines in Patients with Acute Lymphoblastic Leukemia
Gabriele Stocco, Raffaella Franca, Federico Verzegnassi, Margherita Londero, Marco Rabusin, Giuliana Decorti · 2013 · Frontiers in Genetics
Cysteine Scanning Mutagenesis of Transmembrane Domain 10 in Organic Anion Transporting Polypeptide 1B1
Shuichi Ohnishi, Amanda L. Hays, Bruno Hagenbuch · 2014 · Biochemistry
Pharmacogenomics of Rosuvastatin: A Glocal (Global+Local) African Perspective and Expert Review on a Statin Drug
Nyarai Desiree Soko, Collen Mutowembwa Masimirembwa, Collet Dandara · 2016 · OMICS A Journal of Integrative Biology
Pediatric Statin Administration: Navigating a Frontier with Limited Data
Jonathan B. Wagner, Susan M. Abdel‐Rahman · 2016 · The Journal of Pediatric Pharmacology and Therapeutics
Genetic Polymorphisms of Cytochrome P450 Enzymes and Transport Proteins in a Russian Population and Three Ethnic Groups of Dagestan
Karin Badavievich Mirzaev, Dmitry Alekseevich Sychev, Kristina Ryzhikova, O. D. Konova, С. Н. Маммаев, Daniyal Musaevich Gafurov, Г. Н. Шуев, Е. А. Гришина, Zhannet Alimovna Sozaeva · 2017 · Genetic Testing and Molecular Biomarkers
Pharmacogenetic Analysis of OATP1B1, UGT1A1, and BCRP Variants in Relation to the Pharmacokinetics of Letermovir in Previously Conducted Clinical Studies
Julie Kobie, Zifang Guo, Carolyn R. Cho, Karsten Menzel, Jacqueline B. McCrea, Rebecca L. Blanchard, Peter Martin Shaw · 2019 · The Journal of Clinical Pharmacology
Association of SLCO1B1 and ABCB1 Genetic Variants with Atorvastatin-induced Myopathy in Patients with Acute Ischemic Stroke
Limin Zhang, Hong Lv, Qian Zhang, Dongzhi Wang, Xixiong Kang, Guojun Zhang, Xingang Li · 2019 · Current Pharmaceutical Design
Organic Anion Transporting Polypeptide–Mediated Hepatic Uptake of Glucuronide Metabolites of Androgens
Cindy Yanfei Li, Anshul Gupta, Zsuzsanna Gáborik, Emese Kis, Bhagwat Prasad · 2020 · Molecular Pharmacology
Precision Medicine in Kidney Transplantation: Just Hype or a Realistic Hope?
Ehsan Nobakht, Muralidharan Jagadeesan, Rohan Paul, Jonathan S. Bromberg, Sherry Dadgar · 2021 · Transplantation Direct
Statin treatment effectiveness and the SLCO1B1 *5 reduced function genotype: Long‐term outcomes in women and men
Deniz Türkmen, Jane A. H. Masoli, Chia‐Ling Kuo, Jack Bowden, David R. Melzer, Luke C. Pilling · 2022 · British Journal of Clinical Pharmacology
Epidemiological and genetic features of anti-3‑hydroxy-3-methylglutaryl-CoA reductase necrotizing myopathy: Single-center experience and literature review
Diana Prieto-Pena, Javier Gonzalo Ocejo-Vinyals, Joel Mazariegos-Cano, Ana L. Pelayo‐Negro, Sara Remuzgo‐Martínez, Fernanda Genre, Alicia García Dorta, Mónica Renuncio‐García, Víctor Manuel Martínez-Taboada, Carmen García‐Ibarbia et al. · 2022 · European Journal of Internal Medicine
Effect of ABCB1 Genotype on Pre- and Post-Cardiac Transplantation Plasma Lipid Concentrations
Anne B. Taegtmeyer, Jane B. Breen, John P. Smith, Paula Rogers, Gerd Achim Kullak-Ublick, Magdi Habib Yacoub, Nicholas Robert Banner, Paul J.R. Barton · 2011 · Journal of Cardiovascular Translational Research
Serious statin‐associated myotoxicity and rhabdomyolysis in A boriginal and T orres S trait I slanders: a case series
Genevieve M. Gabb, Agnes Isabelle Vitry, Vidya Sadanand Limaye, G. Alhami · 2013 · Internal Medicine Journal
Cardiovascular Pharmacogenomics – Implications for Patients with Chronic Kidney Disease
L. Cavallari, Darius L. Mason · 2016 · Advances in Chronic Kidney Disease
Pharmacogenomics of statin therapy
Jemma C. Hopewell, Christina A. Reith, Jane Armitage · 2014 · Current Opinion in Lipidology
Emerging real-time technologies in molecular medicine and the evolution of integrated ‘pharmacomics’ approaches to personalized medicine and drug discovery
Elizabeth A. Milward, Nilofar Daneshi, Daniel M. Johnstone · 2012 · Pharmacology & Therapeutics
A Genome-Wide Association Study Primer for Clinicians
Tzu‐Hao Wang, Hsin‐Shih Wang · 2009 · Taiwanese Journal of Obstetrics and Gynecology
Genomic and Precision Medicine Approaches in Atherosclerotic Cardiovascular Disease: From Risk Prediction to Therapy—A Review
Andreas Mitsis, Elina Khattab, Michaella Kyriakou, Stefanos Sokratous, Stefanos Sakellaropoulos, Stergios Tzikas, Nikolaos P. E. Kadoglou, George Kassimis · 2025 · Biomedicines
Evidence for Extensive Pleiotropy Among Pharmacogenes
Matthew T. Oetjens, William S. Bush, Joshua C. Denny, Kelly A. Birdwell, Nuri M. Kodaman, Anurag Verma, Holli Hutcheson Dilks, Sarah A. Pendergrass, Marylyn DeRiggi Ritchie, Dana C. Crawford · 2016 · Pharmacogenomics
Development of predictive QSAR models for the substrates/inhibitors of OATP1B1 by deep neural networks
Chunshan Gui, Ying Li, Taotao Peng · 2023 · Toxicology Letters
Cardiovascular pharmacogenomics; state of current knowledge and implementation in practice
Payman Shahabi, Marie‐Pierre Dubé · 2015 · International Journal of Cardiology
How will insights from genetics translate to clinical practice in inflammatory bowel disease?
Eleonora Anna Margaretha Festen, Rinse Karel Weersma · 2014 · Best Practice & Research Clinical Gastroenterology
The Impact of Pharmacogenomics on the Management of Cardiac Disease
Naveen L. Pereira, Richard M. Weinshilboum · 2011 · Clinical Pharmacology & Therapeutics
Promise of Pharmacogenomics for Drug Discovery, Treatment and Prevention of Parkinson's Disease. A Perspective
Haydeh Payami, Stewart Alan Factor · 2013 · Neurotherapeutics
Single nucleotide polymorphism markers for low‐dose aspirin‐associated peptic ulcer and ulcer bleeding
Akiko Shiotani, Takahisa Murao, Yoshihiko Fujita, Yoshinori Fujimura, Takashi Sakakibara, Kazuto Nishio, Ken Haruma · 2014 · Journal of Gastroenterology and Hepatology
Can modulators of apolipoproteinB biogenesis serve as an alternate target for cholesterol-lowering drugs?
Lynley M. Doonan, Edward A A Fisher, Jeffrey L. Brodsky · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Pharmacokinetic and Pharmacogenetic Factors Contributing to Platelet Function Recovery After Single Dose of Ticagrelor in Healthy Subjects
Qian Zhu, Wanping Zhong, Xipei Wang, Liping Mai, Guodong He, Jiyan Chen, Lan Yu Tang, Shuwen Liu, Weihua Lai, Shilong Zhong · 2019 · Frontiers in Pharmacology
Future Directions of Pharmacovigilance Studies Using Electronic Medical Recording and Human Genetic Databases
Young Hee Choi, Chang Yeob Han, Kwi Suk Kim, Sang Geon Kim · 2019 · Toxicological Research
The association of GATM polymorphism with statin-induced myopathy: a systematic review and meta-analysis
Mengyuan Liu, Fangfang Fan, Yan Zhang, Jianping Li · 2020 · European Journal of Clinical Pharmacology
Zebrafish as a Model for the Study of Lipid-Lowering Drug-Induced Myopathies
Magda Dubińska–Magiera, Marta Migocka-Patrzałek, Damian Lewandowski, Małgorzata Daczewska, Krzysztof Jagla · 2021 · International Journal of Molecular Sciences
Marked differences in frequencies of statin therapy relevant SLCO1B1 variants and haplotypes between Roma and Hungarian populations
Ágnes Nagy, Csilla Sipeky, Renáta Szalai, Béla Melegh, Petra Mátyás, Alma Ganczer, Kálmán Tóth, Béla Melegh · 2015 · BMC Genetics
The pleotropic role of statins: Could it be the imminent host modulation agent in periodontics?
Shailly Luthra, Shruti Maroo, Niteeka Maroo, HarpreetSingh Grover · 2013 · Dental Research Journal
Drugs and Rhabdomyolysis: From Liver to Kidney
Biagio Barbano, Liborio Sardo, Maria Ludovica Gasperini, Antonietta Gigante, Marta Liberatori, Gianluca Di Lazzaro, Francesca Di Mario, Barbara Dorelli, Antonio Amoroso, Rosario Cianci · 2015 · Current Vascular Pharmacology
Atorvastatin Treatment Induces Uptake and Efflux Transporters in Human Liver
Linda Björkhem‐Bergman, Helena Bergström, Maria Johansson, Paolo Parini, Mats Eriksson, Anders Rane, Lena Ekström · 2013 · Drug Metabolism and Disposition
The Pharmacogenomics of Anti-Hypertensive Therapy
Sandosh Padmanabhan, Laura J. Paul, Anna F. Dominczak · 2010 · Pharmaceuticals
Clinically relevant genetic variants of drug-metabolizing enzyme and transporter genes detected in Thai children and adolescents with autism spectrum disorder
Chonlaphat Sukasem, Sadeep Medhasi, Ekawat Pasomsub, Natchaya Vanwong, Nattawat Ngamsamut, Apichaya Puangpetch, Monpat Chamnanphon, Yaowaluck Hongkaew, Penkhae Limsila, Darawan Pinthong · 2016 · Neuropsychiatric Disease and Treatment
Optimal design and patient selection for interventional trials using radiogenomic biomarkers: A REQUITE and Radiogenomics consortium statement
D. D. De Ruysscher, G. Defraene, B. Ramaekers, P. Lambin, E. Briers, H. Stobart, T. Ward, S. Bentzen, T. V. van Staa, D. Azria et al. · 2016 · Radiotherapy and Oncology
The Genetics of Ischemic Heart Disease: From Current Knowledge to Clinical Implications
Roberto Elosúa, Sergi Sayols-Baixeras · 2017 · Revista Española de Cardiología (English Edition)
Bioinformatics Approaches to Predict Drug Responses from Genomic Sequencing
Neel S. Madhukar, Olivier Elemento · 2018 · Methods in molecular biology
Impact of SLCO1B1 Genetic Variation on Rosuvastatin Systemic Exposure in Pediatric Hypercholesterolemia
Jonathan B. Wagner, Susan M. Abdel‐Rahman, Andrea Gaedigk, Roger Gaedigk, Geetha Raghuveer, Vincent S. Staggs, Leon van Haandel, James Steven Leeder · 2020 · Clinical and Translational Science
Pharmacogenomic Biomarkers of Susceptibility to Adverse Drug Reactions: Just Around the Corner or Pie in the Sky?
Mark Avigan · 2008 · Personalized Medicine
Pitavastatin: a distinctive lipid-lowering drug
Leiv Ose · 2010 · Clinical Lipidology
Comparative uptake of statins by hepatic organic anion transporting polypeptides
Wilma Kiander, Alli Sinokki, Mikko Neuvonen, Heidi Kidron, Mikko Niemi · 2025 · European Journal of Pharmaceutical Sciences
Strategies for Personalized Medicine–Based Research and Implementation in the Clinical Workflow
Wolfgang Lieb, Henry Völzke, Jill M. Pulley, Dan M. Roden, Heyo K. Kroemer · 2012 · Clinical Pharmacology & Therapeutics
Clinical Perspectives on Targeting Therapies for Personalized Medicine
Donald R.J. Singer, Zoulikha M. Zaïr · 2015 · Advances in protein chemistry and structural biology
Effect of Green Tea Extract and Soy Isoflavones on the Pharmacokinetics of Rosuvastatin in Healthy Volunteers
Weiwei Zeng, Miao Hu, Hon Kit Lee, Elaine Wat, Clara Bik‐San Lau, Chung Shun Ho, Chun Kwok Wong, Brian Tomlinson · 2022 · Frontiers in Nutrition
A gene risk score using missense variants in SLCO1B1 is associated with earlier onset statin intolerance
Margherita Bigossi, Cyrielle Maroteau, Adem Y. Dawed, Alasdair Taylor, Sundararajan Srinivasan, Alaa’ Lufti Melhem, Ewan R. Pearson, Roberto Pola, Colin N A Palmer, Moneeza Kalhan Siddiqui · 2023 · European Heart Journal - Cardiovascular Pharmacotherapy
X chromosome dosage drives statin-induced dysglycemia and mitochondrial dysfunction
Peixiang Zhang, Joseph J. Munier, Carrie B. Wiese, Laurent Vergnes, Jenny C. Link, Fahim Abbasi, Emilio Ronquillo, Katherine Scheker, Antonio Muñoz, Yu‐Lin Kuang et al. · 2024 · Nature Communications
Electronic health records for biological sample collection: feasibility study of statin‐induced myopathy using the C linical P ractice R esearch D atalink
Helen O’Meara, Daniel F. Carr, Jane Evely, Mark R. Hobbs, Gerard McCann, Tjeerd Pieter van Staa, Munir Pirmohamed · 2013 · British Journal of Clinical Pharmacology
Ongoing Challenges in Drug Interaction Safety: from Exposure to Pharmacogenomics
Jane P. F. Bai · 2010 · Drug Metabolism and Pharmacokinetics
A Piece in the Puzzle of Personalized Medicine
Heyo K. Kroemer, Hendrika Meyer, Henriette E. Meyer zu Schwabedissen · 2009 · Clinical Pharmacology & Therapeutics
Safety review of combination drugs for hyperlipidemia
Michel Farnier · 2011 · Expert Opinion on Drug Safety
Impact of Transporter Polymorphisms on Drug Development: Is It Clinically Significant?
Cheynne McLean, Aze Suzanne Wilson, Richard B. Kim · 2016 · The Journal of Clinical Pharmacology